Transport and mode of action of nucleoside derivatives used in chemical and antiviral therapies

Trends in Pharmacological Sciences

Volumn 19, Issue 10, 1998, Pages 424-430

  Pastor Anglada, Marçal ^a   Felipe, Antonio ^a   Javier Casado, F ^a  

^a Reg of Transp Systems Study Group   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXYADENOSINE; ACICLOVIR; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BROXURIDINE; CARRIER PROTEIN; CLADRIBINE; CYTARABINE; DIDANOSINE; DNA; FLOXURIDINE; FLUOROURACIL; FOLIC ACID ANTAGONIST; GEMCITABINE; IDOXURIDINE; LAMIVUDINE; NUCLEOSIDE; NUCLEOSIDE ANALOG; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD TOXICITY; BONE MARROW TOXICITY; CANCER; CELL DIFFERENTIATION; CELL GROWTH; CELL TRANSFORMATION; DNA REPLICATION; DRUG ACTIVATION; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG MECHANISM; DRUG SENSITIVITY; DRUG TRANSPORT; GENE EXPRESSION; HUMAN; MULTIGENE FAMILY; NONHUMAN; NUCLEOSIDE TRANSPORT; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; BIOLOGICAL AVAILABILITY; BIOLOGICAL TRANSPORT, ACTIVE; CARRIER PROTEINS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; HUMANS; NEOPLASMS; NUCLEOSIDES; RATS; SUBSTRATE SPECIFICITY;

EID: 0032192444     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(98)01253-X     Document Type: Review

References (50)

1. Collier A. C.et al. New Engl. J. Med. 334:1997;1011-1017.
2. Lavie A.et al. Nat. Med. 3:1997;922-924.
3. Rubinek T.et al. Eur. J. Biochem. 247:1997;238-247.
4. Agarwal R. P., Olivero O. A. Mutat. Res. 390:1997;223-231.
5. Phillips K. E., Munson A. E. Toxicol. Appl. Pharmacol. 145:1997;260-267.
6. McGinn C. J., Shewach D. S., Lawrence T. S. J. Natl. Cancer Inst. 88:1996;1193-1203.
7. Bouffard D. Y., Momparler R. L. Leuk. Res. 19:1995;849-856.
8. McGinn C. J.et al. Int. J. Radiat. Oncol. Biol. Phys. 30:1994;851-859.
9. Plunkett W., Huang P., Gandhi V. Anticancer Drugs. 6:1995;7-13.
10. Grant S. Adv. Cancer Res. 72:1998;197-233.
11. Shewach D. S., Ellero J., Mancini W. R., Ensminger W. D. Biochem. Pharmacol. 43:1992;1579-1585.
12. Iwasaki H., Huang P., Keating J. J., Plunkett W. Blood. 90:1997;270-278.
13. Hanna N. N.et al. Cancer Res. 57:1997;4025-4209.
14. Pederson L. C.et al. Cancer Res. 57:1997;4325-4332.
15. Cai J., Lee C. W. Biochem. J. 320:1996;991-995.
16. Storniolo A. M., Allerheiligen S. R., Pearce H. L. Semin. Oncol. 24:1997;2-7.
17. Momparler R. L.et al. Anticancer Drugs. 7:1996;266-274.
18. Griffith D. A., Jarvis S. M. Biochim. Biophys. Acta. 1286:1996;153-181.
19. Flanagan S. A., Meckling-Gill K. A. J. Biol. Chem. 272:1997;18026-18032.
20. Pajor A. M., Wright E. M. J. Biol. Chem. 267:1992;3557-3560.
21. Che M., Ortiz D. F., Arias I. W. J. Biol. Chem. 270:1995;13596-13599.
22. Yao S. Y. M.et al. Mol. Pharmacol. 50:1996;1529-1535.
23. Wang J.et al. Am. J. Physiol. 273:1997;F1058-F1065.
24. Schaner M. E.et al. Pharm. Res. 14:1997;1316-1321.
25. Huang Q.et al. J. Biol. Chem. 269:1994;17757-17760.
26. Ritzel M. W. L.et al. Am. J. Physiol. 272:1997;C707-C714.
27. Fang X.et al. Biochem. J. 317:1996;457-465.
28. Yao S. Y. M., Cass C. E., Young J. D. Mol. Pharmacol. 50:1996;388-393.
29. Wang J., Giacomini K. M. J. Biol. Chem. 272:1997;28845-28848.
30. Griffiths M.et al. Nat. Med. 3:1997;89-93.
31. Yao S. Y. M.et al. J. Biol. Chem. 272:1997;28423-28430.
32. Griffiths M.et al. Biochem. J. 328:1997;739-743.
33. Crawford C. R., Patel D. H., Naeve C., Belt J. A. J. Biol. Chem. 273:1998;5288-5293.
34. Huang Q.et al. J. Biol. Chem. 268:1993;20613-20619.
35. Hamilton S. R.et al. J. Physiol. 499P:1997;P50-P51.
36. Felipe A.et al. Biochem. J. 330:1998;991-1001.
37. Gati W. P., Paterson A. R., Larratt L. M., Turner A. R., Belch A. R. Blood. 90:1997;346-353.
38. Goh L. B., Mack P., Lee C. W. Anticancer Res. 15:1995;2575-2580.
39. Jansen W. J.et al. Eur. J. Cancer. 31A:1995;2313-2319.
40. Osses N., Pearson J. D., Yudilevich D. L., Jarvis S. M. Biochem. J. 317:1996;843-848.
41. Ruiz-Montasell B., Felipe A., Casado J., Pastor-Anglada M. J. Membr. Biol. 128:1992;227-233.
42. Pressaco J., Wiley J. S., Jamieson G. P., Erlichman C., Hedley D. W. Br. J. Cancer. 72:1995;939-942.
43. Pressaco J., Mitrovski B., Erlichman C., Hedley D. W. Cancer Res. 55:1995;1505-1508.
44. Ruiz-Montasell B.et al. FEBS Lett. 316:1993;85-88.
45. Felipe A., Ferrer-Martínez A., Casado F. J., Pastor-Anglada M. Biochem. Biophys. Res. Commun. 233:1997;572-575.
46. del Santo, B. et al. Hepatology (in press).
47. Lee C. W., Sokoloski J. A., Sartorelli A. C., Handschumacher R. E. Biochem. J. 274:1991;85-90.
48. Lee C. W., Sokoloski J. A., Sartorelli A. C., Handschumacher R. E. In Vivo. 8:1994;795-802.
49. Lee C. W. Biochem. J. 300:1994;407-412.
50. Anderson C. M.et al. Brain Res. Mol. Brain. Res. 42:1996;358-361.